| Dr Dennis Michael Fisher, MD | |
|
175 S Wilkes Barre Blvd, Wilkes Barre, PA 18702-5040 | |
| (570) 829-2621 | |
| (570) 823-4332 |
| Full Name | Dr Dennis Michael Fisher |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 175 S Wilkes Barre Blvd, Wilkes Barre, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285601245 | NPI | - | NPPES |
| 001093739 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD053937L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Angel's Touch Home Care, Llc | West pittston, PA | Home health agency |
| Geisinger Home Health | Danville, PA | Home health agency |
| Bayada Home Health Care, Inc. | Pittston, PA | Home health agency |
| Pathways Healthcare | Kingston, PA | Home health agency |
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Geisinger-community Medical Center | Scranton, PA | Hospital |
| Geisinger Medical Center | Danville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Caring Community Health Center | 5698004588 | 28 |
| Geisinger Clinic | 5395657001 | 2866 |
| Steffie Enterprises, Inc | 0840225736 | 354 |
News Archive
Targeted therapies attack a cancer's genetic sensitivities. However, it can be difficult to discover the genetics driving a patient's cancer, and the effects of drugs designed to target a genetic abnormality often go beyond their intended target alone. The result is threefold: sometimes a drug is prescribed to treat a target that proves to be irrelevant to the disease, sometimes an existing drug could be used to treat a cancer for which there is no approved targeted therapy, and sometimes a combination of targeted treatments could be used to simultaneously silence more than one genetic cause of a patient's cancer.
Bioheart has announced that the U.S. Patent and Trademark Office issued the company a notice of allowance regarding its patent application 09/858,046, entitled Method For Inducing Angiogenesis By Electrical Stimulation of Muscles.
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.
Adding a missing protein to infertile human sperm can 'kick-start' its ability to fertilise an egg and dramatically increase the chances of a successful pregnancy, a team of Cardiff University scientists have uncovered.
Recently, a team of researchers from the US performed a comprehensive recombination analysis across all medically relevant human coronaviruses, including 158,118 public seasonal hCoV, SARS-CoV-1, SARS-CoV-2, and MERS-CoV genome sequences with the help of the RDP4 software. They aimed at identifying the current and future risks of the emergence of recombinants of SARS-CoV-2
› Verified 1 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Targeted therapies attack a cancer's genetic sensitivities. However, it can be difficult to discover the genetics driving a patient's cancer, and the effects of drugs designed to target a genetic abnormality often go beyond their intended target alone. The result is threefold: sometimes a drug is prescribed to treat a target that proves to be irrelevant to the disease, sometimes an existing drug could be used to treat a cancer for which there is no approved targeted therapy, and sometimes a combination of targeted treatments could be used to simultaneously silence more than one genetic cause of a patient's cancer.
Bioheart has announced that the U.S. Patent and Trademark Office issued the company a notice of allowance regarding its patent application 09/858,046, entitled Method For Inducing Angiogenesis By Electrical Stimulation of Muscles.
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.
Adding a missing protein to infertile human sperm can 'kick-start' its ability to fertilise an egg and dramatically increase the chances of a successful pregnancy, a team of Cardiff University scientists have uncovered.
Recently, a team of researchers from the US performed a comprehensive recombination analysis across all medically relevant human coronaviruses, including 158,118 public seasonal hCoV, SARS-CoV-1, SARS-CoV-2, and MERS-CoV genome sequences with the help of the RDP4 software. They aimed at identifying the current and future risks of the emergence of recombinants of SARS-CoV-2
› Verified 1 days ago
| Entity Name | Caring Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679038293 PECOS PAC ID: 5698004588 Enrollment ID: O20190830001893 |
News Archive
Targeted therapies attack a cancer's genetic sensitivities. However, it can be difficult to discover the genetics driving a patient's cancer, and the effects of drugs designed to target a genetic abnormality often go beyond their intended target alone. The result is threefold: sometimes a drug is prescribed to treat a target that proves to be irrelevant to the disease, sometimes an existing drug could be used to treat a cancer for which there is no approved targeted therapy, and sometimes a combination of targeted treatments could be used to simultaneously silence more than one genetic cause of a patient's cancer.
Bioheart has announced that the U.S. Patent and Trademark Office issued the company a notice of allowance regarding its patent application 09/858,046, entitled Method For Inducing Angiogenesis By Electrical Stimulation of Muscles.
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.
Adding a missing protein to infertile human sperm can 'kick-start' its ability to fertilise an egg and dramatically increase the chances of a successful pregnancy, a team of Cardiff University scientists have uncovered.
Recently, a team of researchers from the US performed a comprehensive recombination analysis across all medically relevant human coronaviruses, including 158,118 public seasonal hCoV, SARS-CoV-1, SARS-CoV-2, and MERS-CoV genome sequences with the help of the RDP4 software. They aimed at identifying the current and future risks of the emergence of recombinants of SARS-CoV-2
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dennis Michael Fisher, MD 100 N Academy Ave, Danville, PA 17822-3034 Ph: (570) 271-6144 | Dr Dennis Michael Fisher, MD 175 S Wilkes Barre Blvd, Wilkes Barre, PA 18702-5040 Ph: (570) 829-2621 |
News Archive
Targeted therapies attack a cancer's genetic sensitivities. However, it can be difficult to discover the genetics driving a patient's cancer, and the effects of drugs designed to target a genetic abnormality often go beyond their intended target alone. The result is threefold: sometimes a drug is prescribed to treat a target that proves to be irrelevant to the disease, sometimes an existing drug could be used to treat a cancer for which there is no approved targeted therapy, and sometimes a combination of targeted treatments could be used to simultaneously silence more than one genetic cause of a patient's cancer.
Bioheart has announced that the U.S. Patent and Trademark Office issued the company a notice of allowance regarding its patent application 09/858,046, entitled Method For Inducing Angiogenesis By Electrical Stimulation of Muscles.
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.
Adding a missing protein to infertile human sperm can 'kick-start' its ability to fertilise an egg and dramatically increase the chances of a successful pregnancy, a team of Cardiff University scientists have uncovered.
Recently, a team of researchers from the US performed a comprehensive recombination analysis across all medically relevant human coronaviruses, including 158,118 public seasonal hCoV, SARS-CoV-1, SARS-CoV-2, and MERS-CoV genome sequences with the help of the RDP4 software. They aimed at identifying the current and future risks of the emergence of recombinants of SARS-CoV-2
› Verified 1 days ago
Dr. Bismah Najeeb, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7399 | |
Weber Wu, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 S Wilkes Barre Blvd, Wilkes Barre, PA 18702 Phone: 570-829-2621 Fax: 570-823-4332 | |
Dr. Melita Konecke, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 575 N River St, Wilkes Barre, PA 18764 Phone: 570-552-7260 Fax: 570-552-7268 | |
Dr. Arundev D Desai, MBBS Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1111 E End Blvd, Wilkes Barre, PA 18711 Phone: 570-824-3521 | |
Stephanie A Gill, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 169 N Pennsylvania Ave, Wilkes Barre, PA 18701 Phone: 570-491-0126 Fax: 570-230-0013 | |
Madhavi Madhurapantula, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 25 Church St, Wilkes Barre, PA 18765 Phone: 570-808-3181 Fax: 570-808-8935 | |
Dr. Natasha May Wu, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-5484 |